Cysteamine Bitartrate

CAS 27761-19-9 7 current recordsSmall Molecule

Who holds supplier records for Cysteamine Bitartrate? 7 organisations hold a current record for Cysteamine Bitartrate: an active US FDA Type II Drug Master File. Recorded organisation countries for current records: India (3) and Italy (2); not recorded for 2.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 13 Nov 2026. How we read these records

Cite as: PharmaTek, “Cysteamine Bitartrate: DMF and CEP holder records”, record as of 13 Nov 2026, pharmatek.co.uk/directory/api/cysteamine-bitartrate

Reading the evidence

  • 7 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • Most recorded organisations are in India

    3 of the 5 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.

  • 4 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (7)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Cysteamine Bitartrate. Country is the organisation's recorded country, not necessarily the manufacturing site.

India3Italy2Country not recorded for 2
Need Cysteamine Bitartrate sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Other forms of this substance

A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:

Overview

Cysteamine Bitartrate is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1200577).

Chemical identity

IUPAC name
2-aminoethanethiol;(2R,3R)-2,3-dihydroxybutanedioic acid
Canonical SMILES
C(CS)N.[C@@H]([C@H](C(=O)O)O)(C(=O)O)O
InChIKey
NSKJTUFFDRENDM-ZVGUSBNCSA-N
Synonyms
Cystagon, Cysteamine bitartrate, Mercamine bitartrate, Mercaptamine bitartrate, Procysbi, RP-103, Mercaptoethylamine bitartrate, CHEBI:50386, Tartrate, Cysteamine, Bitartrate, Cysteamine, RefChem:54919, Cysteamine Tartrate (1:1)

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Cystine Depleting Agent
Mechanism of action
Cystine Disulfide Reduction

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Cysteamine Bitartrate?

7 organisations hold an active US FDA Type II Drug Master File or a CEP for Cysteamine Bitartrate: CAMBREX PROFARMACO MILANO SRL (Italy), ACIC PHARMACEUTICALS INC, BIOPHORE INDIA PHARMACEUTICALS PRIVATE LIMITED (India), HONOUR LAB LTD (India), LUPIN MANUFACTURING SOLUTIONS LTD, Maithri Laboratories Private Limited (India) and RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA SPA (Italy). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Cysteamine Bitartrate Drug Master Files are active?

CAMBREX PROFARMACO MILANO SRL (DMF 9619, 27574), ACIC PHARMACEUTICALS INC (DMF 26816), BIOPHORE INDIA PHARMACEUTICALS PRIVATE LIMITED (DMF 37094), HONOUR LAB LTD (DMF 40328), LUPIN MANUFACTURING SOLUTIONS LTD (DMF 32668), Maithri Laboratories Private Limited (DMF 35758) and RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA SPA (DMF 38209). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

How do I qualify a Cysteamine Bitartrate supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Cysteamine Bitartrate?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.